However, a stepwise analysis of normal mucosa of high risk/no risk patients, dysplastic epithelium, carcinoma in situ, invasive squamous cell cancer, lymph node and distant metastases is needed to fully understand the role of PITX2 and PANCR methylation in development and progression of HNSCC. This evidence concerns the gene PANCR and cancer.